Literature DB >> 1657772

Increased vascular responsiveness to bradykinin in kidneys of spontaneously hypertensive rats. Effect of N omega-nitro-L-arginine.

V Cachofeiro1, A Nasjletti.   

Abstract

We investigated the role of nitric oxide (NO)-dependent and NO-independent mechanisms in mediation of renal vasodilatory responses to bradykinin in spontaneously hypertensive rats (SHR), rats with angiotensin II-induced hypertension (200 ng/min i.p. for 6 days) and the corresponding normotensive control Wistar-Kyoto (WKY) rats and sham-infused rats. To this end, we contrasted the effects of arterial injections of bradykinin and other vasodilators, acetylcholine and sodium nitroprusside, on perfusion pressure and output of cyclic GMP in isolated kidneys perfused with Krebs bicarbonate buffer containing phenylephrine, both with and without N omega-nitro-L-arginine (L-NOARG) (50 microM), an inhibitor of NO synthetase. In kidneys perfused without L-NOARG, all agonists increased the output of cyclic GMP and reduced perfusion pressure, indicative of vasodilation. In kidneys perfused with L-NOARG, vasodilatory responses to bradykinin and acetylcholine were attenuated, and associated effects on output of cyclic GMP were abolished, suggesting dependency on NO synthesis. Irrespective of whether kidneys were perfused with or without L-NOARG, kidneys of SHR were more responsive than kidneys of WKY rats with regard to bradykinin-induced vasodilation. In contrast, vasodilatory responsiveness to bradykinin was nearly equal in perfused kidneys of rats with angiotensin II-induced hypertension and in normotensive controls. Also, vasodilatory responsiveness to acetylcholine and sodium nitroprusside was similar in kidneys of normotensive and hypertensive rats. These data suggest that the renal vasculature of SHR is uniquely and selectively hyperresponsive to bradykinin, with regard to both the NO-dependent and NO-independent vasodilatory actions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657772     DOI: 10.1161/01.hyp.18.5.683

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney.

Authors:  D Fulton; J C McGiff; J Quilley
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

2.  KCa 3.1 channels maintain endothelium-dependent vasodilatation in isolated perfused kidneys of spontaneously hypertensive rats after chronic inhibition of NOS.

Authors:  Serge Simonet; Marc Isabelle; Mélanie Bousquenaud; Nicolas Clavreul; Michel Félétou; Christine Vayssettes-Courchay; Tony J Verbeuren
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 3.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

4.  Preserved regulation of renal perfusion pressure by small and intermediate conductance KCa channels in hypertensive mice with or without renal failure.

Authors:  Ludovic Waeckel; Florence Bertin; Nicolas Clavreul; Thibaut Damery; Ralf Köhler; Jérôme Paysant; Patricia Sansilvestri-Morel; Serge Simonet; Christine Vayssettes-Courchay; Heike Wulff; Tony J Verbeuren; Michel Félétou
Journal:  Pflugers Arch       Date:  2014-06-07       Impact factor: 3.657

5.  Multiple pathways underlying endothelium-dependent relaxation in the rabbit isolated femoral artery.

Authors:  F Plane; T Pearson; C J Garland
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

6.  Cytochrome P450-dependent effects of bradykinin in the rat heart.

Authors:  D Fulton; K Mahboubi; J C McGiff; J Quilley
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

7.  Contribution of calcium-activated potassium channels to the vasodilator effect of bradykinin in the isolated, perfused kidney of the rat.

Authors:  M Rapacon; P Mieyal; J C McGiff; D Fulton; J Quilley
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

8.  Platelet nitric oxide signaling system in patients with coronary artery disease.

Authors:  Mahdi Garelnabi; Vinod Gupta; Venkatesan Mallika; Jayashree Bhattacharjee
Journal:  Ann Vasc Dis       Date:  2011-06-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.